Editorial Team
... Read More
By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. Cookie Policy.
Written By: Editorial Team | Updated : July 16, 2014 5:04 PM IST
A new study has explored the impact of six different rollout strategies by developing a mathematical model of tuberculosis (TB) transmission, care-seeking and diagnostic and treatment practices in India. The researchers explained that while ideally all suspected TB cases would be evaluated with the new test, it was primarily being used only on the highest-risk populations and only in public health clinics, partly because of its cost and the complexity of the nation's health care system.
Approximately 8.6 million people worldwide develop active TB each year, and 1.4 million die from it. Twenty-five percent of all diagnosed TB patients are in India alone. Although treatment for TB is freely available and highly effective, TB continues to kill hundreds of thousands of people every year in India, and vast numbers of cases go undetected. Public TB clinics are better equipped to quickly diagnose and begin treatment for the disease, but patients are often reluctant to utilize them. The researchers say that for better TB tests to make a major difference they must be made available to the private health care providers where patients first seek care. (Read: World Tuberculosis Day 2014: Can the private sector reduce India's TB burden?)
The new test for TB, Xpert MTB/RIF, could diagnose TB in 90 minutes, capture 70 percent of cases missed by microscopy and could also determine if the strain was resistant to rifampin, the most important anti-TB drug. India has begun rolling out this new technology, but since Xpert MTB/RIF was much more expensive than traditional tests, it was currently being implemented mainly in public clinics to test HIV-positive patients who might also have TB or those at high risk of having multidrug-resistant tuberculosis (MDR-TB). (Read: IGRA, the new tuberculosis diagnostic tool pros and cons)
The study found that providing access to Xpert for 20 percent of all individuals seeking care for TB symptoms could reduce new TB cases by 14.1 percent over 5 years, while the "high-risk-only," public-sector strategy currently being implemented might only reduce TB cases by 0.2 percent. However, achieving this result required substantially more resources and appropriate TB treatment. The researchers also found that simply improving the referral network of informal providers to the public sector without any new testing at all it could have as much of an effect on TB as scaling up the new Xpert test. (Read: World Tuberculosis Day 2014: How much do you know about TB? (Quiz))
The study is published in the journal PLOS Medicine.
What is TB?
Tuberculosis is a common infectious disease caused by bacteria called mycobacterium tuberculosis which affects the lungs. Main symptoms of TB are severe cough that lasts for three weeks or longer, bloody or discoloured sputum, night sweats, fever, fatigue and weakness, pain in the chest, loss of appetite, and pain during breathing or coughing. India had the highest total number of TB cases worldwide in 2010 partly due to poor disease management by the private healthcare sector. TB can be prevented by vaccination and maintaining high levels of hygiene. One infected, the patient should follow the medication regimen properly. By not doing so, there are chances of developing resistance to anti-TB drugs resulting in an aggressive form of TB called MDR-TB (multi-drug resistant TB). Read more about World Tuberculosis Day 2014: Tuberculosis causes, symptoms and diagnosis
You may also like to read:
With inputs from ANI
For more articles on Tuberculosis, visit our Tuberculosis section. Follow us on Facebook and Twitter for all the latest updates! For daily free health tips, sign up for our newsletter. And to join discussions on health topics of your choice, visit our forum.
